Total submissions: 20
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000205453 | SCV000261609 | benign | BAP1-related tumor predisposition syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000244636 | SCV000310597 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000205453 | SCV000445473 | benign | BAP1-related tumor predisposition syndrome | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Gene |
RCV000244636 | SCV000518946 | likely benign | not specified | 2018-01-19 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000561863 | SCV000664582 | likely benign | Hereditary cancer-predisposing syndrome | 2016-11-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000561863 | SCV000682546 | likely benign | Hereditary cancer-predisposing syndrome | 2016-03-09 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001172150 | SCV001335114 | benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | BAP1: BP4, BS1, BS2 |
ARUP Laboratories, |
RCV000205453 | SCV001472275 | benign | BAP1-related tumor predisposition syndrome | 2020-02-16 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000244636 | SCV002071061 | benign | not specified | 2019-06-19 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000561863 | SCV002537240 | benign | Hereditary cancer-predisposing syndrome | 2020-10-22 | criteria provided, single submitter | curation | |
Center for Genomic Medicine, |
RCV000244636 | SCV002550824 | likely benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000244636 | SCV002774068 | benign | not specified | 2021-07-23 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002500656 | SCV002811855 | likely benign | BAP1-related tumor predisposition syndrome; Kury-Isidor syndrome | 2021-07-14 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV003316144 | SCV004016327 | benign | Melanoma, uveal, susceptibility to, 2 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
True Health Diagnostics | RCV000561863 | SCV000805224 | likely benign | Hereditary cancer-predisposing syndrome | 2018-06-05 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV001172150 | SCV001740454 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001172150 | SCV001799887 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001172150 | SCV001808346 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001172150 | SCV001970594 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000244636 | SCV002034117 | benign | not specified | no assertion criteria provided | clinical testing |